| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 Oxford University Press
CORRESPONDENCE |
Re: Efficacy of Breast Cancer Screening in the Community According to Risk Level
Affiliations of authors: Wolfson Institute of Preventive Medicine, London, UK (SWD); American Cancer Society, Atlanta, GA (RAS); Mammography Department, Central Hospital, Falun, Sweden (LT)
Correspondence to: Stephen W. Duffy, MSc, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK (e-mail: stephen.duffy@cancer.org.uk).
| The first 10% of the full text of this article appears below. |
The casecontrol study of mammography screening by Elmore and colleagues (1) raises some interesting points. We agree with the sentiment in the accompanying editorial by Harris (2) that evaluation of breast screening in the community is challenging and worthy of further research. We see some of those methodologic challenges in
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 1703-1704.